next steps in the development of cxcr4 inhibitors for mycosis fungoides
Published 2 years ago • 153 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
1:08
the cxcr4/cxcl12 axis as a potential therapeutic target in mycosis fungoides
-
0:47
mechanism of cxcr4 inhibition
-
1:43
potential clinical applications of cxcr4 antagonists in cancer
-
1:04
unmet needs in early-stage mycosis fungoides
-
2:25
how next-generation sequencing will change clinical practice
-
25:05
next generation sequencing 2: illumina ngs sample preparation - eric chow (ucsf)
-
7:33
walk through cluster operations scenarios | initial setup
-
4:23
intro to sequencing by synthesis: industry-leading data quality
-
1:03
real-world data on chlormethine gel for mycosis fungoides
-
1:51
the problem of cultures and the solution of next-gen sequencing, microgen dx
-
0:35
tct 2021: what to look forward to
-
0:50
dr. newhouse explains why developing a check-in system is important
-
12:04
illumina miseq system: how to start a run
-
20:38
update on ongoing trials expanding lvo treatment to include low aspects, low nihss and mevo patients
-
1:08
cch tagetik lets nobis focus on their business
-
8:58
envisioning a transformed clinical trials enterprise for 2030 opening remarks
-
1:38
improved sensitivity for bacterial community characterization in clinical samples
-
2:28
unit 4: introduction to next generation sequencing